Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Current Drug Safety|November 30, 2011
Nevirapine-based regimens in routine clinical settings: results from a large Italian cohort of HIV-1 infected adultsRaffaella Rosso, Roberto Rossotti, Antonio Di Biagio, et al.
Journal of Medical Virology|July 9, 2011
A cluster of patients with recombinant B/F HIV-1 infection: epidemiological, clinical, and virological aspectsRoberto Rossotti, Barbara Foglieni, Chiara Molteni, et al.
Current HIV Research|January 4, 2012
Does GSS still maintain relevance on HAART outcome after the introduction of newest active antiretroviral drugs? 48 weeks resultsMassimiliano Ortu, Paola Vitiello, Fulvio Adorni, et al.
The New Microbiologica|April 6, 2018
Feasibility of all-oral anti-HCV treatment during DHAP chemotherapy and autologous stem cell transplantation for T-cell lymphomaRoberto Rossotti, Chiara Rusconi, Chiara Baiguera, et al.
Sexually Transmitted Infections|October 14, 2024
Challenges and opportunities for hepatitis B virus screening in people attending PrEP services: a retrospective prevalence studyBianca Monti, Roberto Rossotti, Fabiana D'Aloia, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 5, 2013
Optimizing treatment in HIV/HCV coinfectionMassimo Puoti, Roberto Rossotti, Giovanna Travi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 6, 2019
Sustained virological response with 16-week glecaprevir/pibrentasvir after failure to sofosbuvir/velpatasvir in post-transplant severe HCV recurrence in HIVMarco Merli, Roberto Rossotti, Giovanna Travi, et al.
Sexually Transmitted Infections|July 26, 2022
High prevalence of anal papillomavirus infection in men who have sex with men PrEP usersRoberto Rossotti, Alice Nava, Chiara Baiguera, et al.
Transfusion|November 20, 2010
A cluster of human immunodeficiency virus Type 1 recombinant form escaping detection by commercial genomic amplification assaysBarbara Foglieni, Daniel Candotti, Irene Guarnori, et al.
Journal of Viral Hepatitis|February 11, 2023
Impact of treatment with direct-acting antivirals on inflammatory markers and autoantibodies in HIV/HCV co-infected individualsRoberto Rossotti, Marco Merli, Chiara Baiguera, et al.
Pageof 6